Find a Provider

Specialty:: Cytopathology
Pathology
Department Affiliation:: Pathology
Hospital Affiliation:: Ronald Reagan UCLA Medical Center
State License:: A76414
Phone:: 310-825-9288
Health Plans:: Accepted Plans

About Me

Academic Title: Clinical Professor of Pathology and Laboratory Medicine

Department Title: Chief of Gynecology Pathology and Director of Fine Needle Aspiration Clinic

Specialties: Surgical Pathology, Cytopathology, Breast Pathology, Gynecologic Pathology

Links

pathology.ucla.edu
breastcenter.ucla.edu

Primary Office: UCLA Pathology & Lab Medicine
Primary Address: 10833 Le Conte Avenue
Suite 13-145D CHS
Los Angeles, California 90095
: Get Directions
: View Map
Phone: 310-825-9288
Fax: 310-267-2058

Medical Board Certifications: Pathology-Anatomic/Pathology-Clinical, American Board of Pathology, 2004
Certification 2: Cytopathology, American Board of Pathology, 2005
Fellowship: Surgical Pathology, LAC + USC Medical Center, 2003-2004
Fellowship 2: Cytopathology, LAC + USC Medical Center, 2004-2005
Fellowship 3: Pathology, UCLA School of Medicine, 2005-2006
Residency: Anatomic & Clinical Pathology, LAC + USC Medical Center, 1999-2003
Degree: University of Medical Sciences of Iran, MD, 1996

Publications

Conrad R, Yang SE, Chang S, Bhasin M, Sullivan PS, Moatamed NA, Lu DY. Comparison of CytopathologistPerformed Ultrasound-Guided Fine-Needle Aspiration With Cytopathologist-Performed Palpation-Guided FineNeedle Aspiration: A Single Institutional Experience. Arch Pathol Lab Med. 2018.
Kassardjian A, Shintaku PI, Moatamed NA. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas. PLoS One. 2018;13(4):e0195958.
Moatamed NA, DeNicola M, Nham P, Phan RT. Rare occurrence of EGFR exon 19 deletion in invasive lobular carcinoma of the breast. Breast J. 2018;24(3):429-31.
Reddy OL, Shintaku PI, Moatamed NA. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas. Diagn Pathol. 2017;12(1):45.
Yang SE, Sullivan PS, Zhang J, Govind R, Levin MR, Rao JY, Moatamed NA. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology? Cancer Cytopathol. 2016;124(2):100-9.
Woo JS, Apple SK, Sullivan PS, Rao JY, Ostrzega N, Moatamed NA. Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. Diagn Pathol. 2016;11(1):102.
Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-kappaB. Mol Cell Biol. 2016;36(12):1776-92.
Khanlou N, Shintaku P, Yi J, Moatamed NA. Evaluation of PAX8 Expression in Brain Tissue and Related Neoplasms. Appl Immunohistochem Mol Morphol. 2016;24(3):207-9.
Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N, Moatamed NA, Huang J, Koepsell H, Barrio JR, Wright EM. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015;112(30):E4111-9.
Moatamed NA, Wu A, Sarah K, Apple SK. Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up. J Clin Pathol. 2015;68(6):484-7.

Neda A. Moatamed, MD click here to update your profile

Back to search

Find a Provider

Find a Provider

Share this